Advances in Nanomedicines for Interaction with the Intestinal Barrier

The intestinal barrier plays a vital role in maintaining the homeostasis of the gut and the organism. Various nanomedicines with advantages in interacting with the intestinal barrier have been developed for disease treatment. Previous studies indicate multiple interactions between these nanomaterial...

Full description

Bibliographic Details
Main Authors: Sisi Lin, Feng Wu, Zhenping Cao, Jinyao Liu
Format: Article
Language:English
Published: Wiley-VCH 2022-06-01
Series:Advanced NanoBiomed Research
Subjects:
Online Access:https://doi.org/10.1002/anbr.202100147
_version_ 1818233305036750848
author Sisi Lin
Feng Wu
Zhenping Cao
Jinyao Liu
author_facet Sisi Lin
Feng Wu
Zhenping Cao
Jinyao Liu
author_sort Sisi Lin
collection DOAJ
description The intestinal barrier plays a vital role in maintaining the homeostasis of the gut and the organism. Various nanomedicines with advantages in interacting with the intestinal barrier have been developed for disease treatment. Previous studies indicate multiple interactions between these nanomaterials and the intestinal barrier, boosting their applications in promoting the efficiency of oral drug delivery. Recently, numerous elegant nanomedicines have been developed for preventing and treating both intestinal and extraintestinal diseases. Integration of multiple elements with diverse functions into a single type of nanomedicine is beneficial for comprehensive regulation of its interaction with the intestinal barrier and the corresponding treatment efficacy. In this review, the interactions between nanomaterials and the intestinal barrier are discussed following an introduction of the structure and function of the intestinal barrier, with an aim to better understanding the rational design of effective nanomedicines, particularly for oral delivery. Lastly, the applications of oral nanomedicines in treating intestinal barrier dysfunction and relevant diseases, such as inflammatory bowel disease, diabetes, arthritis, and cancer, are highlighted. It is anticipated that this review will stimulate more innovative thinking focused on the intestinal barrier as a critical target for drug delivery and disease treatment.
first_indexed 2024-12-12T11:20:04Z
format Article
id doaj.art-df1a28383cb44dc398de7c73515d033f
institution Directory Open Access Journal
issn 2699-9307
language English
last_indexed 2024-12-12T11:20:04Z
publishDate 2022-06-01
publisher Wiley-VCH
record_format Article
series Advanced NanoBiomed Research
spelling doaj.art-df1a28383cb44dc398de7c73515d033f2022-12-22T00:26:03ZengWiley-VCHAdvanced NanoBiomed Research2699-93072022-06-0126n/an/a10.1002/anbr.202100147Advances in Nanomedicines for Interaction with the Intestinal BarrierSisi Lin0Feng Wu1Zhenping Cao2Jinyao Liu3State Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai 200127 ChinaState Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai 200127 ChinaState Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai 200127 ChinaState Key Laboratory of Oncogenes and Related Genes Shanghai Cancer Institute Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Institute of Molecular Medicine, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai 200127 ChinaThe intestinal barrier plays a vital role in maintaining the homeostasis of the gut and the organism. Various nanomedicines with advantages in interacting with the intestinal barrier have been developed for disease treatment. Previous studies indicate multiple interactions between these nanomaterials and the intestinal barrier, boosting their applications in promoting the efficiency of oral drug delivery. Recently, numerous elegant nanomedicines have been developed for preventing and treating both intestinal and extraintestinal diseases. Integration of multiple elements with diverse functions into a single type of nanomedicine is beneficial for comprehensive regulation of its interaction with the intestinal barrier and the corresponding treatment efficacy. In this review, the interactions between nanomaterials and the intestinal barrier are discussed following an introduction of the structure and function of the intestinal barrier, with an aim to better understanding the rational design of effective nanomedicines, particularly for oral delivery. Lastly, the applications of oral nanomedicines in treating intestinal barrier dysfunction and relevant diseases, such as inflammatory bowel disease, diabetes, arthritis, and cancer, are highlighted. It is anticipated that this review will stimulate more innovative thinking focused on the intestinal barrier as a critical target for drug delivery and disease treatment.https://doi.org/10.1002/anbr.202100147bioavailabilitygut microbiomeintestinal barriernanomedicinesoral delivery
spellingShingle Sisi Lin
Feng Wu
Zhenping Cao
Jinyao Liu
Advances in Nanomedicines for Interaction with the Intestinal Barrier
Advanced NanoBiomed Research
bioavailability
gut microbiome
intestinal barrier
nanomedicines
oral delivery
title Advances in Nanomedicines for Interaction with the Intestinal Barrier
title_full Advances in Nanomedicines for Interaction with the Intestinal Barrier
title_fullStr Advances in Nanomedicines for Interaction with the Intestinal Barrier
title_full_unstemmed Advances in Nanomedicines for Interaction with the Intestinal Barrier
title_short Advances in Nanomedicines for Interaction with the Intestinal Barrier
title_sort advances in nanomedicines for interaction with the intestinal barrier
topic bioavailability
gut microbiome
intestinal barrier
nanomedicines
oral delivery
url https://doi.org/10.1002/anbr.202100147
work_keys_str_mv AT sisilin advancesinnanomedicinesforinteractionwiththeintestinalbarrier
AT fengwu advancesinnanomedicinesforinteractionwiththeintestinalbarrier
AT zhenpingcao advancesinnanomedicinesforinteractionwiththeintestinalbarrier
AT jinyaoliu advancesinnanomedicinesforinteractionwiththeintestinalbarrier